tyrosyl-glycyl-tryptophyl-methionyl-aspartyl-phenylalanyl-glycine: glycine-extended post-translational processing intermediate of progastrin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 130039 |
| SCHEMBL ID | 1372395 |
| MeSH ID | M0163443 |
| Synonym |
|---|
| glycine-extended gastrin 7 |
| (3s)-3-[[(2s)-2-[[(2s)-2-[[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[[(2s)-1-(carboxymethylamino)-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid |
| g-gly 7 |
| 108093-87-4 |
| glycine, n-(n-(n-(n-(n-(n-l-tyrosylglycyl)-l-tryptophyl)-l-methionyl)-l-alpha-aspartyl)-l-phenylalanyl)- |
| glycine-extended pro-gastrin-processing intermediate gl7 |
| tyrosyl-glycyl-tryptophyl-methionyl-aspartyl-phenylalanyl-glycine |
| tyr-gly-trp-met-asp-phe-gly |
| SCHEMBL1372395 |
| DTXSID50148380 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||